✦ LIBER ✦

Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab

✍ Scribed by Mayra J. Sanchez; Maria Buti; Maria Homs; Andres Palacios; Francisco Rodriguez-Frias; Rafael Esteban

Book ID: 116652000
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 180 KB
Volume: 51
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2009.07.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reactivation of chronic hepatitis B viru

Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis

✍ Athina Pyrpasopoulou; Stella Douma; Themistoklis Vassiliadis; Sofia Chatzimichai 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 131 KB

Use of entecavir to prevent hepatitis B

Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy

✍ Riki Okita; Mamoru Takahashi; Hiroyuki Narahara; Yuichi Sanada; Morihito Okada; 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 144 KB

Late onset of hepatitis B virus reactiva

Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy

✍ L. Milazzo; M. Corbellino; A. Foschi; V. Micheli; A. Dodero; A. Mazzocchi; V. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

Hepatitis B virus reactivation in a case

Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and Rituximab despite Adefovir prophylaxis

✍ Yasser Khaled; Amr Hanbali 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 2 views

Reactivation of hepatitis B virus follow

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

✍ Sung-Nan Pei; Chien-Hung Chen; Chuan-Mo Lee; Ming-Chung Wang; Ming-Chun Ma; Tsun 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 166 KB

P168 Hepatitis B virus reactivation in a

P168 Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab)

✍ Zs. Ujj; L. Rejtö; I. Tornai; A. Kiss; B. Telek; Gy. Reményi; P. Ilonczai; M. Ud 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

was longer on retreatment (11 months) than at first treatment (6 months). It is of special interest, that this patient was 83 years old when treated first with radioimmunotherapy and tolerated it on both occasions without side effects or severe cytopenias. In another patient with severe accompanying